37504-98-6

Upstream product

• 124928-70-7 (4S,5S)-5-((S)-1-Hydroxy-ethyl)-2,2-dimethyl-[1,3]dioxolane-4-carbaldehyde 
• 67814-68-0 2,3-O-isopropylidene-D-ribofuranose 
• 124928-73-0 (4S,5R)-5-Ethyl-2,2,5-trimethyl-[1,3]dioxolane-4-carbaldehyde 
• 104331-69-3 5-O-(t-butyldiphenylsilyl)-1-deoxy-3,4-O-isopropyldene-2-C-vinyl-D-ribitol 
• 105544-86-3 5-O-(t-butyldiphenyl)-1-deoxy-3,4-O-isopropylidene-D-ribitol 
• 105544-87-4 5-O-(t-butyldiphenylsilyl)-1-deoxy-3,4-O-isopropylidene-keto-D-erythro-2-pentulose 
• 4159-66-4 (R)-1-((4R,5S)-5-((S)-1-hydroxyethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethane-1,2-diol 
• 93223-61-1 (S)-1-((4S,5R)-5-hydroxymethyl-2,2-dimethyl-1,3-dioxolan-4-yl)ethanol 

Relevant academic research and scientific papers

SYNTHETIC STUDIES OF ERYTHROMYCINS. II. ENANTIOSPECIFIC SYNTHESIS OF A C-10-C-13 SEGMENT OF ERYTHRONOLIDE A FROM D-RIBOSE

(3R,4R,5R)-5-O-Benzyl-2-iodo-3,4-O-isopropylidene-4-methyl-1-heptene-3,4,5-triol 3, a C-10-C-13 synthetic segment of erythronolide A (1) was enantiospecifically synthesized in sixteen steps and 8.3percent overall yield from D-ribose.